Darunavir
Specifications
206361-99-1CAS Number
606-590-1EC Number
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamateIUPAC Name
C27H37N3O7SChemical Formula
547.7 g/molMolecular Weight
Darunavir; 206361-99-1; TMC114; TMC-114; UIC-94017; Darunavirum; TMC 114; (-)-DARUNAVIR; DTXSID0046779; UIC 94017; CHEBI:367163; TMC-41629; YO603Y8113; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; DTXCID8026779; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; ((1S,2R)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-1-benzyl-2-hydroxy-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; ((3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro(5,4-b)furan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate; ((S)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-2-hydroxy-1-((R)-phenylmethyl)-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Ethanolate, Darunavir; RefChem:585195; (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; J05AE10; 114, TMC; UIC94017; Prezista; Darunavirum [INN-Latin]; Derunavir; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; MFCD09260006; CHEMBL1323; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; C27H37N3O7S; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Darunavir [USAN]; NCGC00168773-01; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; DRV; Prezista(TM); Darunavir [INN]; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; AIDS073035; Darunavir (USAN/INN); Darunavir [USAN:INN:BAN]; Prezista Naive; Darunavir?; UNII-YO603Y8113; HSDB 7788; 2idw; 2ien; 3bvb; 3cyw; 3ekt; 3ggu; 3lzs; 3lzu; 3lzv; 3ogp; 3pwm; 3qoz; 3tkw; 3ttp; 4hla; Darunavir (DRV); (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((2S,3R)-4-((4-AMINO-N-ISOBUTYLPHENYL)SULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMATE; TMC41629; TMC 41629; UIC-96017; 2f8g; 2hs1; 2hs2; 3d1z; 3so9; 3t3c; 3u7s; 4ll3; DARUNAVIR [MI]; DARUNAVIR [HSDB]; DARUNAVIR [VANDF]; DARUNAVIR [MART.]; DRV & AAG; DRV & HSA; Epitope ID:231714; DARUNAVIR [WHO-DD]; DARUNAVIR [EMA EPAR]; SCHEMBL118546; BDBM8125; orb1225723; orb1305688; UIC-940T; DARUNAVIR [ORANGE BOOK]; Darunavir, >=98% (HPLC); GTPL11243; 2f80; 2f81; 3d20; 3s53; 3s54; CJBJHOAVZSMMDJ-HEXNFIEUSA-N; GLXC-05003; HMS3715I13; EX-A4009; IVB37837; Tox21_112634; US10806794, Compound Darunavir; Darunavir & alpha1-acid glycoprotein; EBC-27304; MSK169308; s5250; AKOS015966592; CCG-269991; CS-0749; DB01264; FH20801; KS-1469; NCGC00388284-07; NCGC00388284-08; NCGC00388284-10; NCGC00388284-12; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; AC-26778; HY-17040; CAS-206361-99-1; NS00000472; D03656; AB01565837_02; D022705; EN300-20600172; F547231; Q3765251; BRD-K84986517-001-01-8; Z2301684748; ((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-CARBAMIC ACID (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ESTER; (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(ISOBUTYL)AMINO)-1-BENZYL-2-HYDROXYPROPYL)CARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(sup 1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-hydroxy-1-phenylbutan-2-yl}carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl esterSynonyms
Products Containing Darunavir
PREZISTA 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULAPREZISTA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULADARUNAVIR VIVANTA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFGDARUNAVIR TARBIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Page 1 of 4
Companies Selling Darunavir
HR
Hangzhou Royall Import & Export Co.,LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaAI
A.H.A International Co., Ltd.SF
Sandoz Farmaceutica S.A.SpainSA
SANDOZFrancePage 1 of 3